Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)

Axel Grothey, Mark Kozloff, Daniel J. Sargent et al.|Journal of Clinical Oncology|2008

Cited by 695